Independent minds. Global perspective. A publication for the builders
Biotechnology / San Francisco

Emily Weiss.

Co-founder
Ditto Biosciences

Emily Weiss co-founded Ditto Biosciences, which researches proteins from parasites as starting points for autoimmune therapies. Her public biography describes molecular and computational biology. The company combines genome analysis, AI, and protein engineering to investigate biological mechanisms that influence how an immune system responds.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Emily Weiss and the story of Ditto Biosciences.

Ditto's founding team describes drawing on the ways parasites interact with immune defenses. Its public launch treats those evolved mechanisms as a source of candidate molecules to investigate, then engineer for possible therapeutic use. The supplied account connects parasite biology with drug-discovery software and laboratory work. It establishes a research direction without independently demonstrating safety, clinical effectiveness, or a usable treatment for autoimmune disease.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Ditto Biosciences — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗